Additionally, TGM2-dependent covalent CXCL12-Keratine 19 heterodimers can coat cancer cell surfaces, potentially interfering with T-cell-mediated immune responses, suggesting a role for CK-19 in immune regulation (58). The gene discussed is KRT19; the disease is cancer.